Return to List
Results 1–6 of 6
Title Date
1.

Compounded Bioidentical Menopausal Hormone Therapy

Number 532

(Replaces No. 387, November 2007 and No. 322, November 2005)

ABSTRACT: Although improvement in long-term health is no longer an indication for menopausal hormone therapy, evidence supporting fewer adverse events in younger women, combined with its high overall...

August 2012

PDF Format
2.

Emergent Therapy for Acute-Onset Severe Hypertension with Preeclampsia and Eclampsia

Number 514

ABSTRACT: Acute-onset, persistent (lasting 15 minutes or more), severe systolic (greater than or equal to 160 mm Hg) or severe diastolic hypertension (greater than or equal to 110 mm Hg) or both in p...

December 2011

PDF Format
3.

Magnesium Sulfate Use in Obstetrics

Number 573

ABSTRACT: The U.S. Food and Drug Administration advises against the use of magnesium sulfate injections for more than 5–7 days to stop preterm labor in pregnant women. Based on this, the drug classif...

September 2013

PDF Format
4.

Nonobstetric Surgery During Pregnancy

Number 474

(Reaffirmed 2013, Replaces No. 284, August 2003)

ABSTRACT: The American College of Obstetricians and Gynecologists' Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for phy...

February 2011

PDF Format
5.

Subclinical Hypothyroidism in Pregnancy

Number 381

(Reaffirmed 2012)

ABSTRACT: Subclinical hypothyroidism is diagnosed in asymptomatic women when the thyroid-stimulating hormone level is elevated and the free thyroxine level is within the reference range. Thyroid horm...

October 2007

PDF Format
6.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

(Reaffirmed 2013)

Abstract: The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed. As with all patients, antibiotics should be prescribed for pr...

June 2011

PDF Format